Researchers work inside a laboratory at BeiGene’s research and development centre in Beijing. Photo: BloombergResearchers work inside a laboratory at BeiGene’s research and development centre in Beijing. Photo: Bloomberg
Researchers work inside a laboratory at BeiGene’s research and development centre in Beijing. Photo: Bloomberg

Why Chinese biotech companies are not for faint-hearted investors

  • CK Life Sciences is up 97 per cent since announcing favourable clinical trial results for a skin cancer drug four weeks ago
  • But some analysts prefer proven big players with approved drugs and large marketing teams
Topic |   Health in China
Researchers work inside a laboratory at BeiGene’s research and development centre in Beijing. Photo: BloombergResearchers work inside a laboratory at BeiGene’s research and development centre in Beijing. Photo: Bloomberg
Researchers work inside a laboratory at BeiGene’s research and development centre in Beijing. Photo: Bloomberg
READ FULL ARTICLE